Overall rank by patents
#7,388
Across all tracked assignees
USPTO PatentsView assignee record - 44 granted patents across 33 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B61L (GUIDING RAILWAY TRAFFIC; ENSURING THE SAFETY OF RAILWAY TRAFFIC).
The verdict
Cattron holds 44 US patents across 33 technology areas, rank #7,388 of 50,000 tracked assignees.
Cattron North America, Inc. has been granted 44 US utility patents between 2020 and 2025, placing Cattron North America, Inc. at rank #7,388 across all assignees tracked by PlainPatent. This portfolio spans 33 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.0 claims per patent with primary concentration in B61L (GUIDING RAILWAY TRAFFIC; ENSURING THE SAFETY OF RAILWAY TRAFFIC). As a US Corporation, Cattron North America, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Cattron sits between Cardinal Health Switzerland 515 Gmbh (44 patents, rank #7,384) and Commscope Connectivity Spain, S.l. (44 patents, rank #7,392) - the closest US assignees by grant volume. The composite Innovation Score of 57.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 44 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Cattron North America, Inc.'s 21.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 33 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cattron North America, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CARDINAL HEALTH SWITZERLAND 515 GMBH
44 patents
CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
44 patents
CONSOLIDATED EDISON COMPANY OF NEW YORK, INC.
44 patents
CORETECH SYSTEM CO., LTD.
44 patents
Celera, Inc.
44 patents
Celgene CAR LLC
44 patents
CertainTeed Ceilings Corporation
44 patents
CommScope Connectivity Spain, S.L.
44 patents
Cattron North America, Inc.
44 patents
What this shows Cattron holds 44 patents at rank #7,388, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #7,388 in granted patent volume.
Other assignees with the most granted patents in Cattron's primary technology class.
Cattron's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
57 Top 6% higher than 94% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 6 | 13.6% |
| 2021 | 8 | 18.2% |
| 2022 | 9 | 20.5% |
| 2023 | 8 | 18.2% |
| 2024 | 6 | 13.6% |
| 2025 | 7 | 15.9% |
Top 15 of 33 technology areas
Overall rank by patents
#7,388
Across all tracked assignees
57.0 out of 100
How to use this portfolio
Cattron's 44 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.